Biohub researchers have performed what they believe is the first genome-wide CRISPR study of primary human adult skin cells, ...

The speed at which a cell produces proteins is a decisive factor in determining whether it divides, specializes or retains ...

This new technology could one day significantly expand the market for gene-editing biotechs.

As genome editing therapies move through clinical trials to regulatory approval, scientists continue the quest for the holy ...

There's more to young biopharma companies than their numbers, but those numbers are still an important part of each ...

Scribe Therapeutics is the latest biotech to prepare a public listing, as the company looks to propel its lipid-lowering medicines through clinical trials. While the Bay Area biotech has yet to set ...

Spread the love“`html In an age where technology is advancing at breakneck speed, understanding the impact of modern ...